Subcutaneous Buprenorphine Extended-Release Use Among Pregnant and Postpartum Women

Obstet Gynecol. 2021 Feb 1;137(2):377-378. doi: 10.1097/AOG.0000000000004270.
No abstract available

Publication types

  • Comment

MeSH terms

  • Buprenorphine* / therapeutic use
  • Female
  • Humans
  • Opiate Substitution Treatment
  • Opioid-Related Disorders* / drug therapy
  • Opioid-Related Disorders* / epidemiology
  • Postpartum Period
  • Pregnancy

Substances

  • Buprenorphine